The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease.
Semin Nephrol
; 36(4): 319-30, 2016 07.
Article
em En
| MEDLINE
| ID: mdl-27475662
ABSTRACT
The growing prevalence and progression of chronic kidney disease (CKD) raises concerns about our capacity to manage its economic burden to patients, caregivers, and society. The societal direct and indirect costs of CKD and end-stage renal disease are substantial and increase throughout disease progression. There is significant variability in the evidence about direct and indirect costs attributable to CKD and end-stage renal disease, with the most complete evidence concentrated on direct health care costs of patients with advanced to end-stage CKD. There are substantial gaps in evidence that need to be filled to inform clinical practice and policy.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Custos de Cuidados de Saúde
/
Absenteísmo
/
Eficiência
/
Insuficiência Renal Crônica
/
Mortalidade Prematura
/
Presenteísmo
/
Falência Renal Crônica
Tipo de estudo:
Health_economic_evaluation
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Semin Nephrol
Ano de publicação:
2016
Tipo de documento:
Article